Company”) reported consolidated revenues of Baht 496.9 million, decreased by 12.0% compared to quarterly on quarterly (QoQ). The Company’s gross profit was at 31.7% to sales value, declined from QoQ which
financial 0.02 0.08 (0.06) (78.75) Expenses of tax income 5.03 6.76 (1.73) (25.61) Income above expenses / Net income 22.04 27.87 (5.83) (20.92) Profit sharing Attributed to the shareholders of the Company
(3) -103% Elimination (73) (41) 6 108% 115% (228) (134) 41% Profit attributable to owners of the Company 918 1,316 1,386 51% 5% 4,773 5,778 21% Basic earnings per share (Baht) 0.67 0.96 1.01 3.47 4.20
6,731.0 303.7 4.5 Total Operating Expenses 6,352.9 6,216.3 136.6 2.2 Profit 527.1 394.3 132.8 33.7 In 2021, the overall economy began to recover in Q3- 2021 due to the following factors: 1). COVID-19
1,494 8% EBITDA Bio-Based Product Business4/ 113 179 59 -48% -67% 259 238 -8% EBITDA Resource Business5/ 59 133 93 58% -30% 81 226 181% EBITDA Others 6/ (25) (25) (12) 54% 53% (25) (37) -48% Profit
interests of the subsidiaries 0.10 -0.03 0.13 Profit(Loss) attributable to equity holders of the company -20.44 -39.68 19.24 48.48 Financial Position as at June 30 , 2017 and December 31, 2016 (Unit : Million
) 14.64 14.70 Gross profit (loss) 7.46 6.13 2.52 2.47 4.94 196.12 Other revenues 2.33 1.91 4.16 4.07 (1.83) (44.09) Distribution cost (5.15) (4.23) (6.56) (6.42) (1.41) (21.54) Administrative expenses
Financial cost (0.31) (0.06) (0.69) (0.15) 0.38 (54.95) Profit (loss) before income tax expenses (32.74) (6.05) (31.11) (6.59) (1.62) 5.52 Income tax (expense) revenue 5.65 1.04 (7.33) (1.55) 12.98 (177.07
) 61.24% (801.30) (564.93) (389.80) 60.64%Total comprehensive income (loss) attributable to owners of the parent Operating Profit (Loss) EBITDA Net Profit (Loss) Total Comprehensive income for ther period